Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein R* is an isotopically labeled hydroxypropyl moiety.
Bristol-Myers Squibb Company
A C C C A A
A61P C07D C07B C07B A61P A61K
inventional inventional inventional additional inventional inventional
Jun Yaofeng Bach D. Brad D. Weiqi
Li Cheng Tran Maxwell Chen